On March 2, 2023, Sesen Bio, Inc announced that at its special meeting of shareholders held on March 2, 2023, the shareholders approved its pending merger with Carisma Therap Therapeutics Inc.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.33 USD | +0.76% | -1.48% | -54.61% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-54.61% | 55.25M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.26% | 21.96B | |
-8.65% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- CARM Stock
- News Carisma Therapeutics, Inc.
- Declaration of Voting Results by Sesen Bio, Inc